Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer
Hour-by-Hour Action Plan: 48 Hours to Board Meeting Guiding Principle: Patient safety is non-negotiable. Transparency, even when painful, is the only sustainable path. The goal is to act with speed, integrity, and strategic precision to protect patients, the company’s long-term viability, and regulatory trust.Read the full answer